Slovenia-based Kemofarmacija has put out a tender offer to take over drug distributor Pharmafarm, now held by Lek Pharmatech and a number of individual shareholders, for 2.5 million euros. Pharmafarm's majority shareholder is Kemofarmacija, based in Ljubljana, which owns 59.9%, while Lek Pharmatech Romania owns 35.1%. The remaining 4.9% are held by individual shareholders.
Pharmafarm is listed on RASDAQ, and its market capitalisation reaches approximately 3.7 million euros. The Slovenians are offering 7,918 ROL/share, while Pharmafarm last traded for 4,600 ROL/share. At the end of last month, Germany's Celesio, the leading drug distributor and retailer in Europe, announced it would take over 31.4% in Kemofarmacija from the Lek pharmaceutical group, planning to get the rest of the shares, as well. ZF
Pentru alte știri, analize, articole și informații din business în timp real urmărește Ziarul Financiar pe WhatsApp Channels
